Source link : https://newshealth.biz/health-news/tnbc-outcomes-show-progress/
TOPLINE: Neoadjuvant chemotherapy (NACT) use in triple-negative breast cancer (TNBC) increased from 19.1% to 56.4% between 2010 and 2021, with pathologic complete response (pCR) rates rising from 19.6% to 40.3%. Black patients showed lower likelihood of receiving NACT and achieving pCR than non-Hispanic White patients. METHODOLOGY: NACT has evolved as the standard treatment for high-risk […]
The post TNBC Outcomes Show Progress first appeared on News Health.
Author : News Health
Publish date : 2025-03-28 12:43:00
Copyright for syndicated content belongs to the linked Source.